{"id":"NCT02886702","sponsor":"Fougera Pharmaceuticals Inc.","briefTitle":"A Study Comparing Tazarotene Cream 0.05% to TAZORAC速 (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis","officialTitle":"A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC速 (Tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-19","primaryCompletion":"2017-08-02","completion":"2017-08-02","firstPosted":"2016-09-01","resultsPosted":"2018-08-29","lastUpdate":"2018-08-29"},"enrollment":855,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Tazarotene Cream 0.05%","otherNames":["Tazarotene"]},{"type":"DRUG","name":"TAZORAC速 (tazarotene) Cream 0.05%","otherNames":["Tazarotene"]},{"type":"DRUG","name":"Placebo","otherNames":["Vehicle"]}],"arms":[{"label":"Test","type":"EXPERIMENTAL"},{"label":"Reference","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC速 (tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis","primaryOutcome":{"measure":"Treatment Success Assessed by IGA","timeFrame":"Week 12","effectByArm":[{"arm":"Test","deltaMin":60.8,"sd":null},{"arm":"Reference","deltaMin":63.2,"sd":null},{"arm":"Placebo","deltaMin":56,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":"0.3520"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":284},"commonTop":["Application site pain","Application site pruritus","Application site erosion","Application site erythema","Headache"]}}